nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.402	0.52	CbGbCtD
Prazosin—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.371	0.48	CbGbCtD
Prazosin—MT3—nerve—amyotrophic lateral sclerosis	0.00992	0.106	CbGeAlD
Prazosin—Priapism—Riluzole—amyotrophic lateral sclerosis	0.00748	0.0977	CcSEcCtD
Prazosin—MT3—hindbrain—amyotrophic lateral sclerosis	0.00743	0.0792	CbGeAlD
Prazosin—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.00571	0.0609	CbGeAlD
Prazosin—MT3—brainstem—amyotrophic lateral sclerosis	0.00426	0.0454	CbGeAlD
Prazosin—Cataract—Riluzole—amyotrophic lateral sclerosis	0.0038	0.0496	CcSEcCtD
Prazosin—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00349	0.0456	CcSEcCtD
Prazosin—MT3—medulla oblongata—amyotrophic lateral sclerosis	0.00297	0.0316	CbGeAlD
Prazosin—SLC22A3—tongue—amyotrophic lateral sclerosis	0.00276	0.0294	CbGeAlD
Prazosin—MT3—spinal cord—amyotrophic lateral sclerosis	0.00265	0.0282	CbGeAlD
Prazosin—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0313	CcSEcCtD
Prazosin—MT3—nervous system—amyotrophic lateral sclerosis	0.00223	0.0238	CbGeAlD
Prazosin—KCNH7—nervous system—amyotrophic lateral sclerosis	0.00223	0.0238	CbGeAlD
Prazosin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0291	CcSEcCtD
Prazosin—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00221	0.0289	CcSEcCtD
Prazosin—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00219	0.0234	CbGeAlD
Prazosin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0284	CcSEcCtD
Prazosin—MT3—central nervous system—amyotrophic lateral sclerosis	0.00215	0.0229	CbGeAlD
Prazosin—KCNH7—central nervous system—amyotrophic lateral sclerosis	0.00215	0.0229	CbGeAlD
Prazosin—KCNH7—cerebellum—amyotrophic lateral sclerosis	0.0021	0.0224	CbGeAlD
Prazosin—MT3—cerebellum—amyotrophic lateral sclerosis	0.0021	0.0224	CbGeAlD
Prazosin—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.0021	0.0274	CcSEcCtD
Prazosin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00209	0.0273	CcSEcCtD
Prazosin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0249	CcSEcCtD
Prazosin—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00185	0.0241	CcSEcCtD
Prazosin—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00183	0.0195	CbGeAlD
Prazosin—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00181	0.0236	CcSEcCtD
Prazosin—MT3—brain—amyotrophic lateral sclerosis	0.00171	0.0182	CbGeAlD
Prazosin—KCNH7—brain—amyotrophic lateral sclerosis	0.00171	0.0182	CbGeAlD
Prazosin—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00169	0.018	CbGeAlD
Prazosin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00161	0.021	CcSEcCtD
Prazosin—KCNH6—nervous system—amyotrophic lateral sclerosis	0.00159	0.0169	CbGeAlD
Prazosin—Tension—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0203	CcSEcCtD
Prazosin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00154	0.0201	CcSEcCtD
Prazosin—KCNH6—central nervous system—amyotrophic lateral sclerosis	0.00153	0.0163	CbGeAlD
Prazosin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0192	CcSEcCtD
Prazosin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00143	0.0186	CcSEcCtD
Prazosin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0186	CcSEcCtD
Prazosin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0185	CcSEcCtD
Prazosin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0182	CcSEcCtD
Prazosin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0181	CcSEcCtD
Prazosin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00135	0.0176	CcSEcCtD
Prazosin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00133	0.0174	CcSEcCtD
Prazosin—SLC22A3—embryo—amyotrophic lateral sclerosis	0.00132	0.0141	CbGeAlD
Prazosin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0172	CcSEcCtD
Prazosin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0169	CcSEcCtD
Prazosin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0166	CcSEcCtD
Prazosin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0164	CcSEcCtD
Prazosin—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00126	0.0134	CbGeAlD
Prazosin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0163	CcSEcCtD
Prazosin—KCNH6—brain—amyotrophic lateral sclerosis	0.00122	0.013	CbGeAlD
Prazosin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00118	0.0154	CcSEcCtD
Prazosin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0152	CcSEcCtD
Prazosin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0151	CcSEcCtD
Prazosin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00115	0.015	CcSEcCtD
Prazosin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00115	0.015	CcSEcCtD
Prazosin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0145	CcSEcCtD
Prazosin—Pain—Riluzole—amyotrophic lateral sclerosis	0.0011	0.0144	CcSEcCtD
Prazosin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0011	0.0144	CcSEcCtD
Prazosin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0139	CcSEcCtD
Prazosin—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00105	0.0112	CbGeAlD
Prazosin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00103	0.0134	CcSEcCtD
Prazosin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0133	CcSEcCtD
Prazosin—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.000966	0.0103	CbGeAlD
Prazosin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000951	0.0124	CcSEcCtD
Prazosin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000926	0.0121	CcSEcCtD
Prazosin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000913	0.0119	CcSEcCtD
Prazosin—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.000901	0.0096	CbGeAlD
Prazosin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000883	0.0115	CcSEcCtD
Prazosin—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.000881	0.00939	CbGeAlD
Prazosin—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.000867	0.00924	CbGeAlD
Prazosin—ORM1—spinal cord—amyotrophic lateral sclerosis	0.000861	0.00917	CbGeAlD
Prazosin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000853	0.0111	CcSEcCtD
Prazosin—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.000848	0.00904	CbGeAlD
Prazosin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000821	0.0107	CcSEcCtD
Prazosin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000814	0.0106	CcSEcCtD
Prazosin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000813	0.0106	CcSEcCtD
Prazosin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000808	0.0106	CcSEcCtD
Prazosin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000767	0.01	CcSEcCtD
Prazosin—ORM1—nervous system—amyotrophic lateral sclerosis	0.000726	0.00773	CbGeAlD
Prazosin—ORM1—central nervous system—amyotrophic lateral sclerosis	0.000699	0.00744	CbGeAlD
Prazosin—ADRA1B—brain—amyotrophic lateral sclerosis	0.000689	0.00733	CbGeAlD
Prazosin—ADRA1D—brain—amyotrophic lateral sclerosis	0.000673	0.00718	CbGeAlD
Prazosin—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.000665	0.00708	CbGeAlD
Prazosin—HTR1D—nervous system—amyotrophic lateral sclerosis	0.000659	0.00702	CbGeAlD
Prazosin—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.000652	0.00694	CbGeAlD
Prazosin—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.00065	0.00693	CbGeAlD
Prazosin—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.00064	0.00682	CbGeAlD
Prazosin—SLC22A3—nervous system—amyotrophic lateral sclerosis	0.000635	0.00677	CbGeAlD
Prazosin—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.000634	0.00676	CbGeAlD
Prazosin—SLC22A3—central nervous system—amyotrophic lateral sclerosis	0.000612	0.00652	CbGeAlD
Prazosin—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.00058	0.00618	CbGeAlD
Prazosin—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000579	0.00616	CbGeAlD
Prazosin—HTR1A—nervous system—amyotrophic lateral sclerosis	0.000549	0.00585	CbGeAlD
Prazosin—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.000529	0.00563	CbGeAlD
Prazosin—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.000517	0.0055	CbGeAlD
Prazosin—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000516	0.0055	CbGeAlD
Prazosin—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.000512	0.00546	CbGeAlD
Prazosin—SLC22A1—brain—amyotrophic lateral sclerosis	0.000508	0.00541	CbGeAlD
Prazosin—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.000506	0.00539	CbGeAlD
Prazosin—HTR1D—brain—amyotrophic lateral sclerosis	0.000503	0.00536	CbGeAlD
Prazosin—KCNH2—nervous system—amyotrophic lateral sclerosis	0.000489	0.00521	CbGeAlD
Prazosin—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.000487	0.00519	CbGeAlD
Prazosin—SLC22A3—brain—amyotrophic lateral sclerosis	0.000486	0.00517	CbGeAlD
Prazosin—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.000476	0.00507	CbGeAlD
Prazosin—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.000471	0.00501	CbGeAlD
Prazosin—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.00046	0.0049	CbGeAlD
Prazosin—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.000457	0.00487	CbGeAlD
Prazosin—ABCB1—embryo—amyotrophic lateral sclerosis	0.000447	0.00476	CbGeAlD
Prazosin—HTR1A—brain—amyotrophic lateral sclerosis	0.00042	0.00447	CbGeAlD
Prazosin—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000413	0.0044	CbGeAlD
Prazosin—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000409	0.00436	CbGeAlD
Prazosin—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000397	0.00423	CbGeAlD
Prazosin—ADRA1A—brain—amyotrophic lateral sclerosis	0.000387	0.00412	CbGeAlD
Prazosin—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000385	0.0041	CbGeAlD
Prazosin—KCNH2—brain—amyotrophic lateral sclerosis	0.000374	0.00398	CbGeAlD
Prazosin—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00037	0.00395	CbGeAlD
Prazosin—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000362	0.00386	CbGeAlD
Prazosin—ABCG2—brain—amyotrophic lateral sclerosis	0.000332	0.00354	CbGeAlD
Prazosin—CYP1A1—brain—amyotrophic lateral sclerosis	0.000316	0.00336	CbGeAlD
Prazosin—ADRA2A—brain—amyotrophic lateral sclerosis	0.000294	0.00313	CbGeAlD
Prazosin—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000285	0.00304	CbGeAlD
Prazosin—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000254	0.00271	CbGeAlD
Prazosin—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000214	0.00228	CbGeAlD
Prazosin—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000206	0.0022	CbGeAlD
Prazosin—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000202	0.00215	CbGeAlD
Prazosin—ABCB1—brain—amyotrophic lateral sclerosis	0.000164	0.00175	CbGeAlD
Prazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	4.35e-05	0.000763	CbGpPWpGaD
Prazosin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	4.34e-05	0.00076	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.33e-05	0.00076	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	4.29e-05	0.000752	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	4.28e-05	0.00075	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	4.24e-05	0.000743	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	4.17e-05	0.000732	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	4.09e-05	0.000718	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—SOD1—amyotrophic lateral sclerosis	4.07e-05	0.000713	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.03e-05	0.000706	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	4.02e-05	0.000705	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	4.01e-05	0.000703	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—C3—amyotrophic lateral sclerosis	3.99e-05	0.0007	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—DAO—amyotrophic lateral sclerosis	3.96e-05	0.000694	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.95e-05	0.000692	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.9e-05	0.000683	CbGpPWpGaD
Prazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	3.87e-05	0.000678	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.83e-05	0.000672	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	3.81e-05	0.000668	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VCP—amyotrophic lateral sclerosis	3.81e-05	0.000668	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.79e-05	0.000665	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.79e-05	0.000664	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.78e-05	0.000663	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.78e-05	0.000663	CbGpPWpGaD
Prazosin—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	3.76e-05	0.000658	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	3.69e-05	0.000647	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	3.66e-05	0.000642	CbGpPWpGaD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	3.65e-05	0.00064	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	3.65e-05	0.00064	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	3.61e-05	0.000632	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	3.59e-05	0.00063	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	3.54e-05	0.000621	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	3.54e-05	0.000621	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.54e-05	0.00062	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	3.5e-05	0.000614	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	3.48e-05	0.00061	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.46e-05	0.000607	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.46e-05	0.000607	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	3.44e-05	0.000603	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	3.43e-05	0.000601	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.35e-05	0.000588	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.35e-05	0.000588	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	3.31e-05	0.000581	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	3.3e-05	0.000579	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	3.28e-05	0.000575	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	3.26e-05	0.000572	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VCP—amyotrophic lateral sclerosis	3.26e-05	0.000572	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	3.24e-05	0.000568	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.22e-05	0.000564	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.22e-05	0.000564	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	3.19e-05	0.000559	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	3.16e-05	0.000554	CbGpPWpGaD
Prazosin—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	3.14e-05	0.000551	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	3.11e-05	0.000545	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.09e-05	0.000541	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	3.04e-05	0.000533	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.02e-05	0.00053	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	3e-05	0.000526	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PLB1—amyotrophic lateral sclerosis	3e-05	0.000526	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.99e-05	0.000524	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.95e-05	0.000516	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.94e-05	0.000516	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.91e-05	0.00051	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.88e-05	0.000504	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.86e-05	0.000501	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.85e-05	0.0005	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.84e-05	0.000498	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.84e-05	0.000497	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.81e-05	0.000492	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.77e-05	0.000486	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.77e-05	0.000485	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GSR—amyotrophic lateral sclerosis	2.77e-05	0.000485	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.75e-05	0.000483	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	2.74e-05	0.00048	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.74e-05	0.00048	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.71e-05	0.000475	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.71e-05	0.000475	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.7e-05	0.000473	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.68e-05	0.00047	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.64e-05	0.000462	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.62e-05	0.00046	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.6e-05	0.000455	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.54e-05	0.000445	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.53e-05	0.000444	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.51e-05	0.00044	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.5e-05	0.000439	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.48e-05	0.000435	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.46e-05	0.000432	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.44e-05	0.000429	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.42e-05	0.000424	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.4e-05	0.000422	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.4e-05	0.00042	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.39e-05	0.00042	CbGpPWpGaD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.38e-05	0.000418	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.36e-05	0.000413	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	2.35e-05	0.000412	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.33e-05	0.000408	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.33e-05	0.000408	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.32e-05	0.000407	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.3e-05	0.000404	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	2.27e-05	0.000398	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.26e-05	0.000397	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.26e-05	0.000396	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.23e-05	0.000392	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.23e-05	0.00039	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.18e-05	0.000383	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.18e-05	0.000383	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.16e-05	0.000379	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.09e-05	0.000367	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.09e-05	0.000366	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.07e-05	0.000364	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.07e-05	0.000363	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.05e-05	0.000359	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.04e-05	0.000359	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.04e-05	0.000357	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.02e-05	0.000354	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.99e-05	0.000349	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.97e-05	0.000345	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.97e-05	0.000345	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.92e-05	0.000337	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.92e-05	0.000337	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.91e-05	0.000335	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.91e-05	0.000334	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.9e-05	0.000333	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.88e-05	0.00033	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.87e-05	0.000328	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—APOE—amyotrophic lateral sclerosis	1.86e-05	0.000327	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.85e-05	0.000325	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.85e-05	0.000324	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.79e-05	0.000315	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.79e-05	0.000313	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.79e-05	0.000313	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.72e-05	0.000302	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.71e-05	0.0003	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.7e-05	0.000299	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.7e-05	0.000298	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.7e-05	0.000298	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.66e-05	0.000292	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.66e-05	0.000291	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.62e-05	0.000284	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.61e-05	0.000283	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.6e-05	0.000281	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.59e-05	0.000279	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.58e-05	0.000277	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.57e-05	0.000276	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.56e-05	0.000274	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.56e-05	0.000273	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.55e-05	0.000271	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.55e-05	0.000271	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.54e-05	0.000269	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.51e-05	0.000265	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.48e-05	0.00026	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.48e-05	0.00026	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.46e-05	0.000255	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.44e-05	0.000253	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.44e-05	0.000252	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.42e-05	0.000249	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.41e-05	0.000248	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.41e-05	0.000248	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.4e-05	0.000246	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.4e-05	0.000246	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.4e-05	0.000246	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.37e-05	0.00024	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.32e-05	0.000232	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.32e-05	0.000231	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.32e-05	0.000231	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.32e-05	0.000231	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.31e-05	0.000229	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.28e-05	0.000224	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.27e-05	0.000223	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.25e-05	0.00022	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	0.000217	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.23e-05	0.000216	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.23e-05	0.000216	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.22e-05	0.000215	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	1.22e-05	0.000215	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.22e-05	0.000214	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.21e-05	0.000212	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.21e-05	0.000212	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.19e-05	0.000209	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	1.18e-05	0.000207	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.17e-05	0.000205	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.17e-05	0.000204	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.14e-05	0.000199	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.13e-05	0.000198	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	0.000197	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.09e-05	0.000192	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.09e-05	0.000191	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.09e-05	0.000191	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.07e-05	0.000188	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.06e-05	0.000185	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.06e-05	0.000185	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.02e-05	0.000178	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000177	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1e-05	0.000176	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.98e-06	0.000175	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.82e-06	0.000172	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.72e-06	0.00017	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.38e-06	0.000165	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.35e-06	0.000164	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.31e-06	0.000163	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	9.29e-06	0.000163	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	9.23e-06	0.000162	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.93e-06	0.000157	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.44e-06	0.000148	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.41e-06	0.000147	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.38e-06	0.000147	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.31e-06	0.000146	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.29e-06	0.000145	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.12e-06	0.000142	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.09e-06	0.000142	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.01e-06	0.00014	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	7.99e-06	0.00014	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.92e-06	0.000139	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.76e-06	0.000136	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.73e-06	0.000136	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.72e-06	0.000135	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.46e-06	0.000131	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.17e-06	0.000126	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.11e-06	0.000125	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.87e-06	0.00012	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.77e-06	0.000119	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.47e-06	0.000113	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	6.38e-06	0.000112	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.38e-06	0.000112	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.33e-06	0.000111	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.25e-06	0.00011	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.12e-06	0.000107	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.08e-06	0.000107	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.95e-06	0.000104	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.9e-06	0.000104	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.62e-06	9.86e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.49e-06	9.63e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.48e-06	9.6e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.37e-06	9.42e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.3e-06	9.3e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.29e-06	9.27e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.05e-06	8.85e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.99e-06	8.76e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.91e-06	8.61e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.64e-06	8.14e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.6e-06	8.06e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.48e-06	7.86e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.37e-06	7.67e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.17e-06	7.31e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.15e-06	7.28e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.01e-06	7.02e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.82e-06	6.69e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.39e-06	5.94e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.15e-06	5.52e-05	CbGpPWpGaD
